Operational Context

Embryo transfer increases the number of offspring from genetically selected donor females, accelerates dissemination of selected genotypes within and across herds and flocks, and facilitates international trade in germinal products as an alternative to live animal movement.

In dairy and beef cattle industries, ET is integrated into breeding programmes alongside artificial insemination and IVP to concentrate genetic merit from elite donors into commercial recipient herds. It addresses the reproductive constraint that limits donor females to one or a few offspring per year under natural conditions.

In small ruminants, ET is used at lower scale in nucleus flocks and breeding cooperatives to propagate traits including prolificacy, growth rate, and milk yield. In equine industries — sport and racing — ET allows performance mares to continue competition while producing foals via recipient mares.

ET supports disease-control objectives by enabling international movement of genetic material with lower pathogen transmission risk than live animal trade, subject to international sanitary standards for embryo processing and donor health. International commercial ET businesses provide superovulation, collection, cryopreservation, and export certification services linking breeding companies, producer groups, and export markets.

ET is also applied in conservation breeding of rare breeds and endangered species, and in research contexts to manipulate gestational environments or propagate specific genotypes.

Biological Impact

Embryo transfer subjects donor and recipient females to repeated hormonal administration, mechanical intervention in the reproductive tract, and in many species surgical procedures, producing documented acute physiological stress and associated risks of complications.

Donor cattle undergoing superovulation with FSH and PGF2α show transient cortisol and heart rate elevations associated with repeated injections and handling. A study on in vivo embryo production and transfer in heifers documented increased plasma cortisol during artificial insemination and embryo flushing, and elevated heart rate during restraint and insemination, with multiple protocol components each contributing measurable stress responses.

Transcervical catheterisation, rectal palpation, and uterine manipulation in cattle cause discomfort. Epidural lidocaine is used specifically to reduce straining and discomfort during flushing and transfer. Potential complications include uterine or cervical trauma from catheterisation, haematuria, and haemorrhage, particularly in heifers and small ruminants with narrow cervices.

Transvaginal oocyte retrieval (OPU/TVOR) for IVP can produce minor ovarian changes — follicular wall hardening, hypertrophy, and blood-filled follicles — though these are described as minor in cattle when performed by experienced operators.

Surgical and laparoscopic procedures in sheep, goats, pigs, and camelids involve general or regional anaesthesia, abdominal incisions, and manipulation of reproductive organs. Associated risks include post-operative pain, peritoneal adhesions, and wound complications. Repeated superovulation may affect ovarian reserve and uterine environment in donors, with reduced fertility in repeatedly flushed animals described in veterinary breeding literature.

Recipient females undergo hormonal synchronisation and, in non-surgical species, transcervical embryo deposition. In surgical-transfer species, recipients undergo the same anaesthetic and laparoscopic or laparotomy risks as donors.

Scale & Distribution

Global prevalence: High for cattle; Low to Medium for other species
Primary regions: North America, South America (particularly Brazil and Argentina), Europe, Australia and New Zealand, parts of Asia including China
Species coverage: Specific — bovine use dominates; minority use in sheep, goats, horses, pigs, and camelids
Trend: Increasing — driven primarily by growth in IVP cattle embryo production; lower but growing use in small ruminants and equine sectors

IETS 2023 statistics recorded 565,111 bovine embryos transferred by 115 reporting businesses in one major collection network, with IVP embryos outnumbering in vivo-derived embryos by a ratio of approximately 3.5:1. Broader IETS global data document approximately 1.3 million bovine embryo transfers worldwide in 2018 compared with 17,868 in sheep and 8,157 in goats, indicating strong concentration of ET use in cattle and in regions with intensive dairy and beef breeding programmes. The United States, Brazil, China, and Australia are prominent users for bovine ET and IVP. Reporting depends on voluntary submission by practitioners and may under-represent small operators and non-reporting regions.

Regulatory Framing

Embryo transfer is permitted in all major livestock-producing jurisdictions; regulation addresses sanitary standards for international trade, practitioner qualifications, and procedural welfare requirements rather than prohibiting the practice.

Internationally, WOAH Terrestrial Animal Health Code and the IETS Manual of the International Embryo Transfer Society provide technical standards for collection, processing, storage, and movement of embryos, specifying washing protocols, trypsin treatment conditions, and donor health surveillance criteria to minimise disease transmission. These standards underpin sanitary certification for international trade in bovine, ovine, caprine, porcine, and equine embryos.

In the European Union, Regulation (EU) 2016/429 (Animal Health Law) and Delegated Regulation (EU) 2020/686 set conditions for establishments handling germinal products and for trade and movement of embryos, including approval of embryo collection and production teams, traceability requirements, health certificates, and disease control provisions.

In Australia, Queensland’s Animal Care and Protection (Codes of Practice) Amendment Regulation states that surgical embryo transfer and laparoscopic procedures in sheep are required to be performed only by veterinary surgeons or under their direct supervision, with mandatory minimisation of procedural risk. National and state codes of practice for cattle, sheep, and goats require trained personnel and appropriate aseptic technique.

In the United States, ET is governed by state veterinary practice acts with no federal ban. American Embryo Transfer Association guidelines and IETS recommendations govern technical procedures, sanitary standards, and record-keeping. Welfare constraints are embedded in professional veterinary standards rather than ET-specific legislation.

Regulatory variation influences where surgical ET procedures are performed, with more invasive procedures constrained to veterinary surgeons in higher-income jurisdictions while formal ET regulatory frameworks are less developed in some low- and middle-income countries.

Terminology

Embryo transfer, ET, bovine embryo transfer, ovine embryo transfer, caprine embryo transfer, equine embryo transfer, porcine embryo transfer, camelid embryo transfer, surgical embryo transfer, non-surgical embryo transfer, transcervical embryo transfer, laparoscopic embryo transfer, laparotomy embryo transfer, embryo flushing, uterine flushing, superovulation, superstimulation, multiple ovulation and embryo transfer, MOET, in vivo derived embryo, IVD embryo, in vitro produced embryo, IVP embryo, ovum pick-up, OPU, transvaginal oocyte retrieval, TVOR, transvaginal follicular aspiration, TVFA, embryo collection team, embryo production team, germinal products, germplasm, oocytes and embryos, embryo export, embryo import, embryo health certificate

Editorial correction notice

Biological impact — species coverage: Detailed physiological welfare data are concentrated in cattle, primarily addressing short-term cortisol and heart rate responses. Data for sheep, goats, pigs, horses, and camelids are limited; most available information derives from case series or expert opinion in veterinary manuals rather than controlled epidemiological studies.

Biological impact — complication rates: Systematic data on complication incidence — uterine trauma, post-operative infection, adhesion formation, donor fertility decline — are not available at population scale. Available figures derive from case series and expert opinion rather than large-scale epidemiological studies.

Scale distribution — reporting coverage: IETS and national ET association statistics depend on voluntary practitioner reporting and may under-represent small operators and non-reporting regions. Global figures for sheep, goat, horse, pig, and camelid ET are less comprehensively documented than bovine figures.

Regulatory framing — low- and middle-income countries: Formal ET regulatory frameworks are less developed in many low- and middle-income countries. Available regulatory documentation is concentrated in the EU, United States, and Australia.